Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3?

NDM-expressing Escherichia coli infections are challenging to treat, due to limited treatment options. E. coli with four-amino acid inserts (YRIN/YRIK) are also common in India and it has been reported to reduce the susceptibility to aztreonam/avibactam and the clinically used triple combination cef...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakthavatchalam, Yamuna Devi, Shankar, Abirami, Manokaran, Yuvasri, Walia, Kamini, Veeraraghavan, Balaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985326/
https://www.ncbi.nlm.nih.gov/pubmed/36880086
http://dx.doi.org/10.1093/jacamr/dlad016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985326/
https://www.ncbi.nlm.nih.gov/pubmed/36880086
http://dx.doi.org/10.1093/jacamr/dlad016

Ejemplares similares